Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
-
Tornado’s CustomVac Division Enters Private Label Manufacturing Agreement With Ascend Hydrovacs
-
BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET
-
Skyharbour’s JV Partner Orano Commences 6-7,000m Summer Drilling Program at the Preston Uranium Project
-
PBK Miner launches new 2-day XRP cloud mining contracts in response to surge in demand from short-term yield investors
-
IQAI Pakistan Strategy Seminar Concludes Successfully, Deeply Empowering Local Traders
-
Dimensional Fund Advisors Ltd. : Form 8.3 - WAREHOUSE REIT PLC - Ordinary Shares
-
Petrus Resources Announces Renewal of Normal Course Issuer Bid
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
-
Abaxx Announces Digital Title Pilot to Unlock the Collateral Value of Physical Commodities Through its Integrated Market Infrastructure
-
Metro Celebrates the MVPs of Summer: Ontario Farmers and Producers
-
Erdene Announces Results of Annual and Special Meeting of Shareholders
-
Yachting: A summer of events at the Yacht Club de Monaco
-
BILT awarded $15 Million STRATFI contract to support US Air Force maintainers
-
Invivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infectio
-
GDS Announces Results of Annual General Meeting of Shareholders
-
Serve Robotics Brings Autonomous Robot Delivery to Atlanta with Uber Eats, Shake Shack and Local Favorites
-
CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline
-
Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH
-
Churchill Resources Announces Fully Subscribed $700,000 Private Placement and Strategic Leadership Changes to Bolster Growth and Operational Execution
-
Lantronix Selected by Tier-1 U.S. Wireless Operator to Digitally Monitor 50,000+ Cell Site Generators
-
NexGold Infill Drilling Continues to Intersect High Grade Gold Mineralization at the Goldboro Gold Project; 3.58 g/t Gold Over 18.3 Metres, 2.79 g/t gold over 19.7 Metres and 103.50 g/t Gold Over 0.7
-
Aya Gold & Silver Launches Drill Exploration Program at Zgounder Far East and Adds 6 New Regional Permits
-
Range Resources Publishes 2024-2025 Corporate Sustainability Report
-
Medicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
-
Mobilicom and Palladyne AI Partner to Deliver Cybersecure Autonomy for Drones, Industrial Robots and Other Unmanned Systems
-
Wedbush Securities Enhances Client Offering Through Trading Infrastructure Upgrade with Rapid Addition’s Messaging Platform
-
Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations
-
Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity
-
GXO Launches GXO IQ, a First-of-its-Kind AI-first Platform to Power Global Supply Chain Operations
-
Aduro Clean Technologies Welcomes David Weizenbach as Chief Operating Officer
-
OTC Markets Group Welcomes Star Copper Corp. to OTCQX
-
OTC Markets Group Welcomes ITAFOS INC. to OTCQX
-
OTC Markets Group Welcomes Santacruz Silver Mining Ltd. to OTCQX
-
Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025
-
Itafos Upgrades to OTCQX® Best Market
-
Orion’s FY’25 Gross Margin Increased to 25.4% (+230 bps) on Revenue of $79.7M; Expects 5% Revenue Growth and Improved Bottom Line Performance in FY’26; Call Today at 10am ET
-
Opus Genetics Announces VEGA-3 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
-
Born for Switch – AGI Technology Launches High-Speed microSD Express Card TF338
-
Blue Moon Awards Mining Contract for the Construction of the Portal and Exploration Decline for Its Blue Moon Mine in Mariposa County, California
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UNITE GROUP PLC/THE - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - MITIE GROUP PLC - Ordinary Shares
-
DSV – H1 2025 analyst conference call
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - EMPIRIC STUDENT PROPERTY PLC - Ordinary Shares
-
I-Mab Highlights Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
-
ProFound Therapeutics Announces Multi-Year Strategic Collaboration with Novartis to Discover and Develop Novel Therapeutics for Cardiovascular Disease
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Reddit Inc. Investors with Substantial Losses to Contact the Firm
-
Nature’s Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock
